{"product_id":"tirzepatide-20mg","title":"Tirzepatide 20mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTirzepatide is a laboratory-synthesized 39-amino acid synthetic peptide functioning as a unimolecular dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is structurally based on the native GIP sequence with targeted modifications — including a C20 fatty diacid acyl chain attached via a linker at position 20 — conferring an extended plasma half-life of approximately 5 days and balanced co-agonism (GIPR:GLP-1R potency ratio ≈ 5:1 in vitro, with near-native GIP potency and approximately 20% GLP-1 potency relative to native ligands).\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThrough simultaneous activation of both incretin receptors in controlled laboratory settings, Tirzepatide serves as an investigative research tool for studying dual incretin receptor signaling mechanisms and their downstream metabolic pathway effects. Key research applications include:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eDual GIP\/GLP-1 receptor co-agonism and incretin signaling pathway dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlycemic regulation mechanism research and glucose homeostasis pathway modeling\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative incretin pathway analysis versus selective GLP-1 receptor agonism in preclinical systems\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCardiometabolic endpoint modeling and metabolic pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eType 2 diabetes experimental model research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD) pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eObesity-related comorbidity endpoint modeling in controlled preclinical systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThese molecular characteristics position Tirzepatide as a valuable investigative tool for elucidating the mechanistic basis of dual incretin receptor targeting across multiple metabolic research paradigms in controlled laboratory environments.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862330273976,"sku":"9351648004549","price":200.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862330306744,"sku":"9351648004556","price":340.0,"currency_code":"USD","in_stock":true},{"title":"40mg","offer_id":52862330339512,"sku":"9351648004693","price":600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/variant-13.jpg?v=1771486905","url":"https:\/\/p1peptides.com\/products\/tirzepatide-20mg","provider":"p1peptides","version":"1.0","type":"link"}